期刊文献+

肺癌组织蛋白激酶C活性和亚型的测定及其临床意义 被引量:1

Detection of protein kinase C and its isoform expression in lung cancer tissues and its clinical significance
下载PDF
导出
摘要 目的 研究肺癌组织蛋白激酶C活性、亚型及其临床意义。方法 从23例肺癌患者4种类型的新鲜组织取材,测定其蛋白激酶C活性及亚型,并与正常肺组织作比较。结果 肺癌组织蛋白激酶C活性明显高于正常肺组织(t=2.46,P〈0.05),而且以细胞膜的升高更为明显(t=4.63,P〈0.01),表现出典型的转膜现象;4种类型肺癌组织的蛋白激酶C活性未见统计学差异(P〉0.05)。肺癌各年龄组、吸烟组与非吸烟组的蛋白激酶C活性无统计学差异(P〉0.05)。按pTNM分期比较,自Ⅰ期~Ⅲb期,细胞质和细胞膜的蛋白激酶C活性逐渐升高,但各期间差异无显著性(P〉0.05)。肺癌组织蛋白激酶C活性随分化程度增高而降低,以未分化癌为最高。另外,蛋白激酶C—a在肺癌组织胞浆的表达较正常肺组织胞浆明显增高(P〈0.05)。结论 蛋白激酶C活性显著增高可能在肺癌发生中有重要作用,可能是一种判断肺癌进展和分化程度的重要标志物。 Objective To assess the clinical significance of protein kinase C(PKC) in lung cancer tissues. Methods Fresh lung cancer tissues of four pathological types were collected in 23 cases, and the PKC activity and isoform were measured and compared with those of normal lung tissues. Results Both cytoplasm and membrane fractions of lung cancer tissues exhibited higher PKC activity than those of normal tissues (t = 2.46, P (0.05), and more obvious in membrane fractions (t= 4.63, P〈 0. 01), which showed translocation from cytoplasm to membrane ; PKC activity had no significant difference among the four pathological types (P〉0. 05). There was no obvious difference in different age groups,between smokers and nonsmokers; PKC activity in cytoplasm and membrane fractions increased gradually from pTNM Ⅰ to Ⅲ b phase, but no obvious difference was showed between different phase. In addition, PKC activity decreased following the increase of differentiation level, the highest was in undifferentiated cancer. Protein kinase C-a is more higher in plasm of lung cancer tissues than that of normal lung tissues(P〈0.05). Conclusion PKC plays a significant role in lung carcinogenesis,and it may be one of the most important cancer markers to judge the progression and differentiation degree of lung cancer.
出处 《实用肿瘤杂志》 CAS 2008年第3期211-214,共4页 Journal of Practical Oncology
基金 教育部归国人员博士启动基金(2004-527)
关键词 肺肿瘤 蛋白激酶C 同工酶类 癌基因 基因 肿瘤抑制基因 lung neoplasms protein kinase C isoenzymes oncogenes genes,tumor suppressors
  • 相关文献

参考文献12

  • 1Koivunen J, Aaltonen V, Peltonen J. Protein kinase C (PKC) family in cancer progression [J]. Cancer Lett,2006,235 (1): 1-10.
  • 2Mulsow J J, Watson RW, Fitzpatrick JM, et al. Transforming growth factor-beta promotes profibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling [J]. Ann Surg, 2005,242 (6) :880- 887.
  • 3Zhang L, Huang J, Yang N ,et al. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma [J]. Cancer Res, 2006,66 (9) : 4627 -4635.
  • 4Carter CA, Kane CJ. Therapeutic potential of natural compounds that regulate the activity of protein kinase C[J]. Curr Med Chem,2004,11(21):2883-2902.
  • 5王士勇,杨振君,何安光.牛精子蛋白激酶C抑制剂逆转KB/VCR的作用及其机理[J].肿瘤防治杂志,2003,10(7):683-686. 被引量:3
  • 6Lahn M, Su C, Li S, et al. Expression levels of protein kinase C-alpha in non-small cell lung cancer [J]. Clin Lung Cancer,2004,6(3):184-189.
  • 7毛伟征,苏东明,李雪萍,等.AJCC癌症分期手册[M].第6版.沈阳:辽宁科技出版社,2005.167-178.
  • 8Kern M, Pahlke G, Balavenkatraman KK, et al. Apple polyphenols affect protein kinase C activity and the onset of apoptosis in human colon carcinoma cells [J]. J Agric Food Chem, 2007,55(13):4999-5006.
  • 9Mackay HJ, Twelves CJ. Targeting the protein kinase C family., are we there yet [J]. Nat Rev Cancer, 2007,7 (7) : 554- 562.
  • 10Pan Q,Bao LW, Kleer CG,et al. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy[J]. Cancer Res, 2005, 65 (18): 8366-8371.

二级参考文献5

共引文献3

同被引文献12

  • 1李拥军,尹宜发,熊刚,李思维.肺癌放疗致放射性肺炎的多因素分析[J].实用肿瘤杂志,2006,21(4):302-305. 被引量:14
  • 2Zhang S, Wang 1,, Liu H, et al. Enhancement .f reeomhinant myrice|in on the radiosen,'.,itivily of hmg cancer A549 and 111299 cells[ J ]. Diagn Pathol, 2(114,9 (1) :68.
  • 3Kim .JIt, Khn IH, Shin Jtl, el a.]. Sequen'e-dependenl vadlosensitizalion of historic deacefylase inhibitors trichos- latin a and SK-7041 [ J]. Cant'er lies Treat, 2013,45(4):334-342.
  • 4Nishida N, Mimori K, Fabbri M, et al. MicroRNA-125a- 5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab [ J ]. Clin Cancer Res, 2011,17(9) :2725 -2733.
  • 5Ufkin ML, Peterson S, Yang X, et al. miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia [J]. Leuk Res,2014,38(3) :402 -410.
  • 6Izzotti A, Calin GA, Arrigo P, et al. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke [ J ]. FASEB J,2009, 23 (3) : 806 - 812.
  • 7Wood PA, Yang X, Hrushesky WJ. Clock genes and cancer[ J]. Integr Cancer Ther,2009,8 (4) :303 - 308.
  • 8Wang G, Mao W, Zheng S, et al. Epidermal growth factor receptor-regulated miR-125a-5p metastatic inhibi- tor of lung cancer [J]. FEBS J, 2009,276(19) :5571 - 5578.
  • 9Cron KR, Zhu K, Kushwaha DS, et al. Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer[ J ]. PLoS One, 2013,8 (9) : e73710.
  • 10Jiang L, Chang J, Zhang Q, et al. MIcroRNA hsa-miR- 125a-3p activates p53 and induces apoptosis in lung cancer cells [ J ]. Cancer Invest, 2013,31 (8) : 538 - 544.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部